Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target
Abstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances in treatment, the molecular mechanisms driving DLBC progression remain incompletely understood, necessitati...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-03-01
|
| Col·lecció: | Hereditas |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s41065-025-00411-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|